sb 203580 has been researched along with astaxanthine in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (astaxanthine) | Trials (astaxanthine) | Recent Studies (post-2010) (astaxanthine) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 1,955 | 70 | 1,422 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HI; Choi, W; Choi, YH; Jeon, SJ; Kim, BW; Kim, JH; Lee, JH; Nam, SW | 1 |
1 other study(ies) available for sb 203580 and astaxanthine
Article | Year |
---|---|
Astaxanthin inhibits H2O2-mediated apoptotic cell death in mouse neural progenitor cells via modulation of P38 and MEK signaling pathways.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Caspase Inhibitors; Cell Culture Techniques; Enzyme Inhibitors; Flavonoids; Hydrogen Peroxide; Imidazoles; MAP Kinase Kinase Kinases; Mice; Oxidants; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Spinal Cord; Stem Cells; Xanthophylls | 2009 |